プログラム
| Time | Content |
|---|---|
| 9:50-10:00 |
開会挨拶 成田 年(星薬科大学 薬理学研究室) |
| 10:00-11:00 |
特別講演Ⅰ Future Prospects of Cancer Research and Cancer Medicine座長:成田 年(星薬科大学 薬理学研究室) 演者:間野 博行(国立がん研究センター) |
| 11:10-12:00 |
Featured Symposium I
FS1-1. Mass Spectrometry for Cancer Neuroimmunology: Tissue, Blood and Breath
FS1-2. Controlling Microglial Phagocytosis for Brain Health and Cancer
FS1-3. Hypothalamic CRH Neurons Orchestrate Brain–Periphery–Tumor Communication |
| 12:15-13:15 |
座長:嶋田 直人(富士フイルム和光純薬株式会社)
The synapse as a starting point: from brain development to cancer neuroscience
Marker Antibodies for Neuroscience from FUJIFILM Wako: Developed to Meet Researchers' Needs |
| 13:20-13:55 |
Oral presentation 座長:南雲 康行(国立がん研究センター研究所 がん患者病態生理研究ユニット)
O-1. Reprogramming Cancer Cell-Derived CNS Tropism into Therapeutic T Cells through T-Cell Signaling
O-2. A neuropeptide receptor as a candidate therapeutic vulnerability in small-cell lung cancer
O-3. Establishment of a Dorsal Root Ganglion and Breast Cancer Spheroid Co-culture Model |
| 14:00-14:40 | Poster presentation |
| 14:45-15:25 |
Sweets Seminar
In vivo reprogramming for biomedical research: Insights into cancer development and tissue rejuvenation |
| 15:35-16:00 |
Frontier Lecture
The history of neural organoid research and its implications for cancer research |
| 16:05-16:55 |
Featured Symposium Ⅱ
FS2-1. Establishment of Human-Derived Cell Resources Supporting Cancer Neuroscience Research
FS2-2. Decoding the Brain Ecosystem: YAP1 Regulation in Glioma and Ependymoma
FS2-3. Shared morphological strategy for collective migration in neurons and glioblastoma cells |
| 17:00-18:00 |
特別講演Ⅱ
Organoid-Based New Approach Methodologies in Cancer and Neuroscience |
| 18:00-18:10 |
閉会挨拶 成田 年(星薬科大学 薬理学研究室) |